Cibc Bancorp Usa Inc. Maxcyte, Inc. Transaction History
Cibc Bancorp Usa Inc.
- $80.8 Billion
- Q3 2025
A detailed history of Cibc Bancorp Usa Inc. transactions in Maxcyte, Inc. stock. As of the latest transaction made, Cibc Bancorp Usa Inc. holds 10,779 shares of MXCT stock, worth $16,060. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,779Holding current value
$16,060% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding MXCT
# of Institutions
118Shares Held
72.7MCall Options Held
0Put Options Held
0-
Cadian Capital Management, LP New York, NY8.91MShares$13.3 Million1.1% of portfolio
-
Black Rock Inc. New York, NY8.14MShares$12.1 Million0.0% of portfolio
-
Morgan Stanley New York, NY7.03MShares$10.5 Million0.0% of portfolio
-
Mirabella Financial Services LLP London, X06.6MShares$9.83 Million1.57% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.59MShares$8.33 Million0.0% of portfolio
About MAXCYTE, INC.
- Ticker MXCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 101,724,000
- Market Cap $152M
- Description
- MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expr...